2008
DOI: 10.1016/j.canlet.2008.03.008
|View full text |Cite
|
Sign up to set email alerts
|

Anti-angiogenic effect of 5-Fluorouracil-based drugs against human colon cancer xenografts

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
37
1
1

Year Published

2008
2008
2017
2017

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 50 publications
(40 citation statements)
references
References 25 publications
1
37
1
1
Order By: Relevance
“…Furthermore, our recent study showed that 5-FU-based drugs have antitumor function partially through up-regulation of TSP-1 in colorectal cancer xenografts (5). In accordance with these results, we also found that 5-FU enhanced the expression of TSP-1 in human colon cancer (KM12C and LOVO cells) and breast cancer MCF7 cells ( Fig.…”
Section: Discussionsupporting
confidence: 87%
See 2 more Smart Citations
“…Furthermore, our recent study showed that 5-FU-based drugs have antitumor function partially through up-regulation of TSP-1 in colorectal cancer xenografts (5). In accordance with these results, we also found that 5-FU enhanced the expression of TSP-1 in human colon cancer (KM12C and LOVO cells) and breast cancer MCF7 cells ( Fig.…”
Section: Discussionsupporting
confidence: 87%
“…Cancer Res 2008; 68: (17 5-FU-based drug, S-1, at sub-MTD concentration has antiangiogenic function through up-regulation of TSP-1 in colorectal cancer xenografts (5). To investigate possible mechanisms underlying the specificity of this effect, human colon cancer cells were treated with 5-FU at concentrations near or below IC 50 for 4 days ( Supplementary Fig.…”
Section: Cancer Researchmentioning
confidence: 99%
See 1 more Smart Citation
“…В предклиниче-ских работах различные формы фторпиримидинов в метрономных дозах показывают свою активность в от-ношении аденокарцином молочной железы, толстой кишки, желудка, светлоклеточного рака поч ки, гепато-целлюлярного рака. Также изучается действие перо-ральных форм фторпиримидинов (UFT, капецитабин, S1) в низких дозировках [85][86][87][88]. Например, капецита-бин в метрономном режиме оказывает антиангиогенное действие в отношении опухолей толстой кишки, реали-зующееся через повышение экспрессии TSP-1 [87].…”
Section: механизм противоопухолевого действия метрономной химиотерапииunclassified
“…Conversely, other studies have shown conflicting results about the role of the enzyme dihydropyrimidine dehydrogenase (DPD), with some showing that a high expression of DPD may enhance the production of 5-FU catabolites, with a subsequent increase of cell toxicity [10], and others showing that DPD activity has a negligible cytotoxic effect on human keratinocytes [11]. In addition, the damage to the upper corion vessels may be fostered indirectly through the inhibition of angiogenesis via the induction of thrombospondin-1 [12].…”
Section: Sirsmentioning
confidence: 99%